1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
TLE3 Is a Novel Fusion Partner of JAK2 in Myeloid/Lymphoid Neoplasm With Eosinophilia Responding to JAK2 Inhibition
(
- Contribution to journal › Article
- 2018
-
Mark
Effects of JAK1/2 inhibition on bone marrow stromal cells of myeloproliferative neoplasm (MPN) patients and healthy individuals
(
- Contribution to journal › Article
- 2015
-
Mark
Evolving Therapeutic Options for Polycythemia Vera : Perspectives of the Canadian Myeloproliferative Neoplasms Group
(
- Contribution to journal › Debate/Note/Editorial